Team Led by Klauber-Demore uses Antibody to Inhibit Tumor Growth
April 22, 2013
April 22, 2013 — A monoclonal antibody targeting a protein known as SFPR2 has been shown by researchers at the University of North Carolina to inhibit tumor growth in pre-clinical models of breast cancer and angiosarcoma.